VCU Massey Cancer Center aims to improve triple negative breast cancer treatments

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

RICHMOND, Va. – VCU Massey Cancer Center in Richmond, which is world-renowned for its cancer research and clinical trials, recently renewed its National Cancer Institute (NCI) designation.

The NCI is the federal government's principal agency for cancer research and training.

Massey is one of 66 cancer centers in the country -- and one of just two centers in Virginia -- with the NCI designation.

That means millions of dollars are going towards research and trials and also helps in recruiting some of the best clinicians in the field.

VCU Massey Cancer Center Director Dr. Gordon Ginder said their mission to find new and innovative ways to treat all cancers, but specifically in the fight against breast cancer.

Ginder said the facility wants to make more advances treating one of the most aggressive types of cancer: triple negative breast cancer.

"So we have specific research focused on those high risk type of breast cancers where we still need to get better outcomes,” Ginder said.

In fact, there are 22 breast cancer trials now underway at Massey and even more are in progress considering all the types of cancers doctors treat at the center.

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.